Skip to content
The Peter Attia Drive

#386 - Aging clocks—what they measure, how they work, and their clinical and real-world relevance

7 months ago

Products mentioned (4)

0:0055:34
▾

Studies cited in this episode (5)

As referenced on air, with the quote and the moment. Reported, not evaluated.

the DO-HEALTH study21:06
“the first study. This was referred to as the do health study. And it's, I think it's a reasonable use case example”
the CALERIE trial34:31
“There's a very famous study called the CALERIE trial. This was run out of Pennington many years ago. Eric Robison, who's a previous guest on the podcast actually was the PI for that. But the data set from CALERIE has been used multiple times. This was a CALERIE restriction study and it showed that, so the CALERIE restriction showed a reduction in in pace of aging using the Dunedin PACE clock”
the Dunedin Multidisciplinary Health and Development Study36:01
“The Dunedin Multidisciplinary Health and Development Study, and I just want to kind of give you the background on where this cohort comes from, has been a very long running longitudinal cohort, as I mentioned, based in New Zealand”
the DO Health trial47:56
“The first study, the DO Health trial, shows that aging clocks can detect small biological changes in response to an intervention. And in this case, it was omega-3 supplementation that appeared to slightly slow several epigenetic clocks over three years.”
the Dunedin PAC-NI paper48:14
“The second study, the Dunedin PAC-NI paper, showed that scientists could build new types of aging clocks, in this case, using structural brain imaging, that appear to capture meaningful patterns related to cognitive decline, frailty, and even overall mortality.”